¼¼°èÀÇ Ç×°¨¿°Á¦ ½ÃÀå : À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø(2023-2030³â)
Anti-Infective Agents Market, By Type, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1401788
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 288 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,503,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,443,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,829,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ÀÇ ÁÖ¿ä ³»¿ë

Ç×°¨¿°Á¦ ½ÃÀå ±Ô¸ð´Â 2022³â 1,374¾ï 6,103¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023³âºÎÅÍ 2030³â±îÁö CAGR 4.2%·Î È®´ëµÉ °ÍÀÔ´Ï´Ù.

Ç×°¨¿°Á¦ ½ÃÀå - ½ÃÀå ¿ªÇÐ

Àü¿°º´ÀÇ À¯Çà°ú °Ç°­ ÁöÇâ Áõ°¡´Â ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù.

Ç×°¨¿°Á¦ ½ÃÀåÀº °¨¿°º´ Áø´ÜÀÇ °¡¿ë¼º°ú Á¶±â Áø´Ü°ú °ü·ÃµÈ ¿¹¹æ °¡´ÉÇÑ À§Çè¿¡ ´ëÇÑ °Ç°­ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåµµ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹ÚÅ׸®¾Æ, ¹ÙÀÌ·¯½º, °õÆÎÀÌ °¨¿°°ú °°Àº °¨¿°¼º ÁúȯÀº ¼¼°èÀûÀ¸·Î Á¡Á¡ ´õ ¸¹Àº »ç¶÷µé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´°ú ½Î¿ì±â À§ÇØ ÇöÀç °­·ÂÇÑ Ç×°¨¿°Á¦ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »õ·Î¿î Àü¿°º´ÀÇ ÃâÇö°ú ¿À·¡µÈ Àü¿°º´ÀÇ ºÎȰ·Î ÀÎÇØ È¿°úÀûÀÎ Ç×°¨¿° ¾à¹°ÀÌ Á¡Á¡ ´õ ¸¹ÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÃÖ±Ù ¹ß»ýÇÑ Äڷγª19¿Í ¿¡º¼¶ó ¹× ÁöÄ« ¹ÙÀÌ·¯½º Àü¿°º´ÀÌ ±× ¿¹ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ »ç°ÇµéÀº ÀÌ·¯ÇÑ Áúº´À» ÅëÁ¦Çϰí Ä¡·áÇÒ ¼ö ÀÖ´Â È¿À²ÀûÀÎ Ä¡·á¹ýÀ» °³¹ßÇÏ°í ½ÇÇàÇÏ´Â °ÍÀÌ ¾ó¸¶³ª ½Ã±ÞÇÑÁö¸¦ º¸¿©ÁÝ´Ï´Ù.

Ç×°¨¿°Á¦ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È ¿¬Æò±Õ ¾à 4.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯Çüº° ¼¼ºÐÈ­¿¡ µû¸£¸é, Ç×¹ÙÀÌ·¯½ºÁ¦´Â ½ÅÈï ½ÃÀå °³Ã´À¸·Î ÀÎÇØ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Åõ¿© °æ·ÎÀÇ ¼¼ºÐÈ­¿¡ µû¸£¸é, ÁÖ·Î ½ÅÁ¦Ç° °³¹ß Áõ°¡·Î ÀÎÇØ 2022³â¿¡´Â °æ±¸Á¦°¡ ÁÖ¿ä À¯ÇüÀÌ µÉ °ÍÀÔ´Ï´Ù.

À¯Åë ä³Îº°·Î´Â ÁÖ·Î ÀÔ¿ø ȯÀÚ ¼ö¿ä Áõ°¡·Î ÀÎÇØ º´¿ø ¾à±¹ÀÌ 2022³â ÁÖ¿ä À¯ÇüÀ¸·Î ²ÅÇû½À´Ï´Ù.

Áö¿ªº°·Î´Â ÇコÄɾî ÀÎÇÁ¶óÀÇ °³¼±À¸·Î ºÏ¹Ì°¡ 2022³â ÁÖ¿ä ¼öÀÍ¿øÀ¸·Î ºÎ»óÇß½À´Ï´Ù.

Ç×°¨¿°Á¦ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è Ç×°¨¿°Á¦ ½ÃÀåÀº À¯Çü, Åõ¿© °æ·Î, À¯Åë ä³Î ¹× Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

Ç×±ÕÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦, Ç×Áø±ÕÁ¦ µî 3°¡Áö·Î ³ª´¹´Ï´Ù. Ç×¹ÙÀÌ·¯½ºÁ¦°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. Ç×¹ÙÀÌ·¯½ºÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ ¸î ³âµ¿¾È Ç×¹ÙÀÌ·¯½ºÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº Åõ¿© °æ·Î¿¡ µû¶ó ±¹¼Ò, °æ±¸, Á¤¸Æ Åõ¿©ÀÇ ¼¼ °¡Áö·Î ³ª´¹´Ï´Ù. °æ±¸Á¦´Â ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ±× ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ´Â °æ±¸¿ë Ä¡·áÁ¦ÀÇ Ãà¼Ò Ãß¼¼¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

½ÃÀåÀº À¯Åë ä³Î¿¡ µû¶ó º´¿ø ¾à±¹, ¼Ò¸Å ¾à±¹, ÀüÀÚ»ó°Å·¡, ±âŸ µî 4°¡Áö·Î ºÐ·ùµË´Ï´Ù. º´¿ø ¾à±¹ÀÌ ½ÃÀåÀ» Áö¹èÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ´Â º´¿ø ³» ȯÀÚ Ä¡·á¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

Ç×°¨¿°Á¦ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ °¡Á® ¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù.

Ç×°¨¿°Á¦ ½ÃÀå - °æÀï ±¸µµ :

½ÃÀå ±â¾÷µéÀº ¾÷°è¿¡¼­ ÀÔÁö¸¦ °­È­Çϱâ À§ÇÑ Àü·«À¸·Î Á¦Ç° ¹üÀ§ È®´ë, R&D ÅõÀÚ, Æ÷Æ®Æú¸®¿À È®ÀåÀ» ÅëÇØ Á¦Ç° ¹üÀ§¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. °úÇÐ, »ý¸í°øÇÐ ¹× Á¦¾à ºÐ¾ßÀÇ ¿¬±¸°³¹ßÀº »õ·Î¿î Ç×°¨¿°Á¦ °³¹ß¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̸¦ À§Çؼ­´Â »õ·Î¿î ¾à¹° Ç¥ÀûÀ» ¹ß±¼Çϰí, ÃÖ÷´Ü ¾à¹° Àü´Þ ¹æ¹ýÀ» °³¹ßÇϸç, Áúº´À» º¸´Ù Á¤È®ÇÏ°Ô Áø´ÜÇÒ ¼ö ÀÖ´Â ÃÖ÷´Ü Áø´Ü ¹æ¹ýÀ» äÅÃÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ½ÃÀå ¼ºÀåÀ» À§ÇÑ ±â¾÷ °£ °ÇÀüÇÑ °æÀïÀ» °¡Á®¿Ã °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Ç×°¨¿°Á¦ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Ç×°¨¿°Á¦ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå Ç×°¨¿°Á¦ ¾÷°è Á¶»ç

Á¦5Àå Ç×°¨¿°Á¦ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå Ç×°¨¿°Á¦ ½ÃÀå ±¸µµ

Á¦7Àå Ç×°¨¿°Á¦ ½ÃÀå - À¯Çüº°

Á¦8Àå Ç×°¨¿°Á¦ ½ÃÀå - Åõ¿© °æ·Îº°

Á¦9Àå Ç×°¨¿°Á¦ ½ÃÀå - À¯Åë ä³Îº°

Á¦10Àå Ç×°¨¿°Á¦ ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - Ç×°¨¿°Á¦ ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Anti-Infective Agents Market size was valued at USD 1,37,461.03 Million in 2022, expanding at a CAGR of 4.2% from 2023 to 2030.

Anti-infectives, such as antibacterials, antivirals, antifungals, and antiparasitic drugs, are treatments that prevent or treat infections. Pre-clinical and clinical research on antimicrobials, antibacterials, antivirals, antifungals, and antiparasitic drugs is included in the category of anti-infective agents.

Anti-Infective Agents Market- Market Dynamics

Increasing prevalence of infectious disease and health consciousness to propel market demand

The Anti-Infective Agents market is also expected to increase as a result of growing health consciousness regarding the availability of infectious illness diagnostics and the preventable risks associated with early diagnosis. Infectious disorders, such as bacterial, viral, and fungal infections, continue to affect more people worldwide. To fight these illnesses, there is now a greater need for potent anti-infective medications. Effective anti-infective drugs are becoming more and more necessary because of the advent of novel infectious diseases or the resurgence of old ones. Some instances of these illnesses are the COVID-19 pandemic that occurred more recently, as well as the Ebola and Zika outbreaks. These incidents demonstrate how urgent it is to create and implement efficient remedies to control and treat these illnesses.

Anti-Infective Agents Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.2% over the forecast period (2023-2030)

Based on Type segmentation, antiviral was predicted to show maximum market share in the year 2022, owing to growing antiviral drug developments.

Based on Route of Administration segmentation, oral segment was the leading type in 2022, mainly due to rise in new product development.

Based on Distribution Channel segmentation, hospital pharmacies was the leading type in 2022, mainly due to growing demand from hospitalized patients.

On the basis of region, North America was the leading revenue generator in 2022, owing to improved healthcare infrastructure.

Anti-Infective Agents Market- Segmentation Analysis:

The Global Anti-Infective Agents Market is segmented on the basis of Type, Route of Administration, Distribution Channel, and Region.

The market is divided into three categories based on Type: antibacterial, antiviral, and antifungal. The antiviral segment dominates the market. The increased demand for antiviral drugs is expected to boost the demand for antiviral agents in the coming years.

The market is divided into three categories based on Route of Administration: topical, oral, intravenous. The oral segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to the growing focus on reducing oral therapies.

The market is divided into four categories based on Distribution Channel: hospital pharmacies, retail pharmacies, e-commerce, and others. The hospital pharmacies dominate the market and is likely to maintain its dominance during the forecast period. This is due to high demand patient treatment in hospitals is boosting the market growth.

Anti-Infective Agents Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Anti-Infective Agents Market- Competitive Landscape:

Market players are increasing the range of products offered, R&D investments, and portfolio expansions as tactics to fortify their positions in the industry. Scientific, biotechnological, and pharmaceutical research developments have aided in the creation of novel anti-infective drugs. It entails identifying fresh targets for drugs, creating cutting-edge drug delivery methods, and employing cutting-edge diagnostic methods to diagnose illnesses more precisely. These factors ere expected to provide healthy competition among companies for market growth.

Recent Developments:

In January 2022, Mankind Pharma launched Saviour Mankind, its division focused on development of injectable medications for life-saving purposes. Its product portfolio includes a wide range of therapeutic solutions, from anti-infective agents.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTI-INFECTIVE AGENTS MARKET KEY PLAYERS

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY TYPE

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY ROUTE OF ADMINISTRATION

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY DISTRIBUTION CHANNEL

GLOBAL ANTI-INFECTIVE AGENTS MARKET, BY REGION

Table of Contents

1. Anti-Infective Agents Market Overview

2. Executive Summary

3. Anti-Infective Agents Key Market Trends

4. Anti-Infective Agents Industry Study

5. Anti-Infective Agents Market: COVID-19 Impact Analysis

6. Anti-Infective Agents Market Landscape

7. Anti-Infective Agents Market - By Type

8. Anti-Infective Agents Market - By Route of Administration

9. Anti-Infective Agents Market - By Distribution Channel

10. Anti-Infective Agents Market- By Geography

11. Key Vendor Analysis- Anti-Infective Agents Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â